“Likely” Merck Consumer-Health Sale Could Bring $8 Billion – Analysts

Merck executives shift their position regarding the potential divestiture of non-pharma assets, including the firm’s consumer-health business. J.P. Morgan analysts expect a sale of the consumer unit, and say Merck’s brands, including Claritin and Coppertone, could grow globally with a new owner.